TITLE

Tailoring therapy to best suit ST-segment elevation myocardial infarction: searching for the right fit

AUTHOR(S)
Armstrong, Paul W.; Welsh, Robert C.
PUB. DATE
October 2003
SOURCE
CMAJ: Canadian Medical Association Journal;10/28/2003, Vol. 169 Issue 9, p925
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Focuses on the application of percutaneous coronary intervention (PCI) on patients with ST-segment elevation myocardial infarction (STEMI) in Canada. Effects of PCI on STEMI patients; Importance of timing in the reperfusion of the infarct-related artery; Steps in enhancing early reperfusion.
ACCESSION #
11105978

 

Related Articles

  • Which guidelines best reflect UK management of ACS?  // PharmacoEconomics & Outcomes News;4/9/2005, Issue 475, p10 

    Discusses research being done on guidelines for the management of acute coronary syndromes in Great Britain. Reference to a study by K. F. Carruthers et al, published in the March 2005 issue of the "Heart"; Perecentage of patients with myocardial infarction who went through reperfusion; Cause...

  • Gender Differences in the Noninvasive Evaluation and Management of Patients with Suspected Coronary Artery Disease. Shaw, Leslee; Miller, Douglas; Romeis, James; Kargl, Deborah; Younis, Liwa; Chaitman, Bernard // Annals of Internal Medicine;4/1/94, Vol. 120 Issue 7, p559 

    Presents a study which determined if gender-based differences exist in the post-test management and clinical outcome of patients with clinically suspected coronary artery disease who have stress electrocardiographic or myocardial perfusion imaging evaluation. Clinical and demographic...

  • Ex Vivo and In Vivo Approaches to Study Mechanisms of Cardioprotection Targeting Ischemia/Reperfusion (I/R) Injury: Useful Techniques for Cardiovascular Drug Discovery. Vidavalur, Ramesh; Swarnakar, Snehasikta; Thirunavukkarasu, Mahesh; Samuel, Samson Mathews; Maulik, Nilanjana // Current Drug Discovery Technologies;Dec2008, Vol. 5 Issue 4, p269 

    The last few decades have seen significant advancement in the therapy of Ischemic Heart Diseases (IHD). This is a direct outcome of the increasing knowledge of the molecular mechanisms involved during an ischemic insult of the myocardium. Even then there is still a major unmet need for better...

  • "No-Reflow" Phenomenon Following Percutaneous Coronary Intervention: An Uncommon Complication. Safi, Arshad M.; Kwan, Tak W. // Angiology;Mar2000, Vol. 51 Issue 3, p247 

    The no-reflow phenomenon has been recognized as an uncommon complication after reperfusion therapy (thrombolytic or mechanical) for acute myocardial infarction and after percutaneous coronary intervention. As management and outcomes differ, early diagnosis and angiographic exclusion of other...

  • Quality Measure Study: Progress in Reducing the Door-to-Balloon Time in Patients with ST-segment Elevation Myocardial Infarction. Nishida, Katsufumi; Hirota, Sean K.; Seto, Todd B.; Smith, Daniel C.; Young, Cathy; Muranaka, Wanda; Beauvallet, Suzanne; Fergusson, David J. // Hawaii Medical Journal;Oct2010, Vol. 69 Issue 10, p242 

    Background: Reperfusion therapy improves both mortality and morbidity in patients with ST-elevation myocardial infarction (STEMI). Timeliness of such reperfusion is an important factor in improving patient survival. For percutaneous coronary intervention (PCI), the American College of Cardiology...

  • Facilitated percutaneous coronary intervention. Brodie, B. R. // Heart;Dec2005, Vol. 91 Issue 12, p1527 

    The article presents a discussion on facilitated percutaneous coronary intervention (PCI) for ST elevation myocardial infarction (STEMI). Facilitated PCI is defined as the use of pharmacological treatment as soon as possible after the onset of STEMI in an attempt to establish early reperfusion,...

  • Management of microvascular dysfunction and reperfusion injury. Prasad, A.; Gersh, B. J. // Heart;Dec2005, Vol. 91 Issue 12, p1530 

    The article presents a discussion on the management of microvascular dysfunction and reperfusion injury. Myocardial contrast echo-cardiography has been available for a many years for the assessment of myocardial perfusion, and the recent availability of intravenous contrast agents has made it...

  • Systemic Inflammation and Reperfusion Injury in Patients With Acute Myocardial Infarction. Blancke, Fien; Claeys, Marc J.; Jorens, Philippe; Vermeiren, Guy; Bosmans, Johan; Wuyts, Floris L.; Vrints, Chris J. // Mediators of Inflammation;12/14/2005, Vol. 2005 Issue 6, p385 

    Despite early recanalization of an occluded infarct artery, tissue reperfusion remains impaired in more than one-third of the acute myocardial infarction (AMI) patients owing to a process of reperfusion injury. The role of systemic inflammation in triggering this phenomenon is unknown....

  • INDIGENOUS RECOMBINANT STREPTOKINASE VS NATURAL STREPTOKINASE IN ACUTE MYOCARDIAL INFARCTION PATIENTS: PHASE III MULTICENTRIC RANDOMIZED DOUBLE BLIND TRIAL. Diwedi, S. K.; Hiremath, J. S.; Kerkar, P. G.; Reddy, Krishna N.; Manjunath, C. N.; Ramesh, S. S.; Prabhavati, S.; Dhobe, M.; Singh, Kavita; Bhusari, P.; Rao, Raman // Indian Journal of Medical Sciences;May2005, Vol. 59 Issue 5, p200 

    BACKGROUND: Streptokinase is the most widely used thrombolytic agent and can now be made using recombinant DNA technology. The present trial was initiated to assess an indigenous recombinant streptokinase (Shankinase, r-SK). AIM: To compare the efficacy and safety of indigenous recombinant...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics